Diversify Wealth Management’s Ascendis Pharma A/S ASND Stock Holding History

Diversify Wealth Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.83M	Buy	11,181 +506	+5%	+$118K	0.05%	311
2026 Q1	$2.35M	Buy	10,675 +2,924	+38%	+$655K	0.04%	333
2025 Q4	$1.67M	Buy	7,751 +457	+6%	+$94.4K	0.08%	236
2025 Q3	$1.47M	Buy	7,294 +155	+2%	+$28.9K	0.08%	220
2025 Q2	$1.4M	Buy	7,139 +1,145	+19%	+$187K	0.09%	225
2025 Q1	$998K	Buy	+5,994	New	+$856K	0.07%	243

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Diversify Wealth Management's ASND Position: Q2 2026 in Review

Diversify Wealth Management increased its Ascendis Pharma A/S (ASND) stake by 4.7% in Q2 2026, buying an estimated $118K and bringing the position to 11,181 shares worth $2.83M. The position accounts for 0.05% of the portfolio, ranked #311.

Diversify Wealth Management first reported a position in ASND in Q1 2025 and has held it in 6 quarters since. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Diversify Wealth Management held 11,181 shares of Ascendis Pharma A/S worth $2.83M as of Q2 2026.
Diversify Wealth Management bought 506 Ascendis Pharma A/S shares in Q2 2026, an estimated $118K.
Ascendis Pharma A/S made up 0.05% of Diversify Wealth Management's portfolio in Q2 2026, its #311 holding.
Diversify Wealth Management first reported a position in Ascendis Pharma A/S in Q1 2025 and has held it in 6 quarters since.
313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Diversify Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.